Bevacizumab Side Effects
>>>Help Community - Post Your Bevacizumab Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Bevacizumab Side Effects
Bevacizumab Safety Reports reported to FDA
Total Bevacizumab reports: 874.Bevacizumab FDA safety alerts: 2004 2005 2006 2007 .
Reported deaths: 194 Reported hospitalizations: 649.
Take Bevacizumab Side Effects Survey or Share Your Bevacizumab Story.
Reported Bevacizumab Side Effects: pyrexia, dehydration, diarrhoea, nausea, vomiting, asthenia, disease progression, pulmonary embolism, death, renal failure acute, anaemia haemolytic autoimmune.
More About Bevacizumab.
If you have questions about Bevacizumab, you can ask a Health Expert or Ask Patient Community about Bevacizumab.
Showing 1-50 of 874 Next >
Bevacizumab Side Effects Report #5253930-5Health Professional from UNITED STATES reported BEVACIZUMAB problem on Feb 28, 2007. Female patient, weighting 98.00 lb, was diagnosed with colon cancer metastatic, metastases to liver and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, hyponatraemia, nausea. BEVACIZUMAB dosage: 5MG/KG Q 2WKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5253983-4
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Feb 28, 2007. Male patient, 76 years of age, weighting 172.0 lb, was diagnosed with tonsil cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, vomiting. BEVACIZUMAB dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5255886-8
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 15, 2007. Male patient, 63 years of age, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, chronic obstructive pulmonary disease, condition aggravated, diverticular perforation, lung infection pseudomonal, lung neoplasm, pulmonary thrombosis, respiratory distress. BEVACIZUMAB dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, VANCOMYCIN HYDROCHLORIDE, FORTAZ, FLAGYL, PROTONIX, NORVASC, PULMICORT, FOLIC ACID. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5258247-0
BEVACIZUMAB problem was reported by a Health Professional from CANADA on Feb 16, 2007. Female patient, 63 years of age, weighting 114.6 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. BEVACIZUMAB dosage: unknown. During the same period patient was treated with CISPLATIN, GEMCITABINE, PLATELETS, PRBC. Patient died on 12/01/2006.
Bevacizumab Side Effects Report #5258571-1
Physician from CANADA reported BEVACIZUMAB problem on Feb 15, 2007. Female patient, 38 years of age, weighting 119.7 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, malignant neoplasm progression, metastases to central nervous system, non-small cell lung cancer, vasculitis. BEVACIZUMAB dosage: 15 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with CISPLATIN, GEMCITABINE, VENTOLIN, TYLENOL #, TYLENOL #, ALTACE. Patient recovered.
Bevacizumab Side Effects Report #5258822-3
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Female patient, weighting 90.00 lb, was diagnosed with colon cancer, metastases to liver and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, hyponatraemia. BEVACIZUMAB dosage: 5MG/KG Q 2 WEEKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5259969-8
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Feb 23, 2007. Female patient, 66 years of age, weighting 220.9 lb, was diagnosed with breast cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cellulitis, culture wound positive, diphtheria, haematocrit decreased, haemoglobin decreased, heart rate increased, pseudomonas infection, purulent discharge. BEVACIZUMAB dosage: 1590 MG, Q3W, INTRAVENOUS. During the same period patient was treated with GEMCITABINE, CALCIUM. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5261561-6
BEVACIZUMAB problem was reported by a Health Professional from CANADA on Feb 20, 2007. Female patient, 65 years of age, weighting 195.1 lb, was diagnosed with breast cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: acidosis, diarrhoea, haemoglobin decreased, intestinal ischaemia, po2 decreased, rectal haemorrhage, tachyarrhythmia. BEVACIZUMAB dosage: 7.5 MG/KG, Q3W, INTRAVENOUS. During the same period patient was treated with TYLENOL, METOPROLOL TARTRATE, ALLOPURINOL, DECADRON, METFORMIN, ARANESP, PAMIDRONATE. Patient died on 11/02/2006.
Bevacizumab Side Effects Report #5261994-8
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 26, 2007. Male patient, 71 years of age, weighting 172.0 lb, was diagnosed with colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dyspnoea, thrombosis in device, tracheitis. BEVACIZUMAB dosage: 5MG/KG Q2W IV. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LIPITOR, NIASPAN, QUANAPRIL, COREG, HEMOCYTE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5262257-7
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 08, 2007. Female patient, weighting 90.00 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, hyponatraemia, nausea. BEVACIZUMAB dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5262707-6
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 05, 2007. Female patient, weighting 155.0 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: wound evisceration. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient recovered.
Bevacizumab Side Effects Report #5265305-3
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 09, 2007. Female patient, weighting 121.3 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, disease progression. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient died on 01/21/2007.
Bevacizumab Side Effects Report #5265451-4
Health Professional from ITALY reported BEVACIZUMAB problem on Mar 07, 2007. Male patient was diagnosed with colorectal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, angina pectoris. BEVACIZUMAB dosage: 300 MG EVERY 14 DAYS. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5265812-3
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 68 years of age, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, haematochezia, haemoglobin decreased, mental status changes, neuropathy, oral intake reduced, prothrombin time abnormal, sedation. BEVACIZUMAB dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, TIMOLOL MALEATE, NEXIUM, COUMADIN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5266760-5
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 23, 2007. Female patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. BEVACIZUMAB dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5266761-7
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 23, 2007. Female patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. BEVACIZUMAB dosage: unknown. Patient died.
Bevacizumab Side Effects Report #5266762-9
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 23, 2007. Female patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: retinal haemorrhage, visual acuity reduced. BEVACIZUMAB dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5266763-0
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 23, 2007. Female patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: retinal haemorrhage. BEVACIZUMAB dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5266764-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 23, 2007. Female patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: disease progression. BEVACIZUMAB dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5266782-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 23, 2007. Female patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hyperlipidaemia, transient ischaemic attack. BEVACIZUMAB dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5266783-6
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 23, 2007. Female patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cataract, disease progression. BEVACIZUMAB dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5266786-1
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 26, 2007. Male patient, 71 years of age, weighting 172.0 lb, was diagnosed with colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dyspnoea, impaired healing, respiratory tract irritation, tracheal haemorrhage. BEVACIZUMAB dosage: 5MG/KG Q2W IV. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LIPITOR, NIASPAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5266795-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 23, 2007. Female patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis. BEVACIZUMAB dosage: unknown. Patient recovered.
Bevacizumab Side Effects Report #5268179-X
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 16, 2007. Female patient, 58 years of age, weighting 163.1 lb, was diagnosed with renal cancer metastatic, metastases to lung and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebral infarction, dysarthria, fall, gait disturbance, haemangioma, wrist fracture. BEVACIZUMAB dosage: 740 MG IV X 1. During the same period patient was treated with PROLEUKIN, ZETIA, PROTONIX, SYNTHROID, IBUPROFEN, NORVASC, BACOLFEN, TRAMADOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5268674-3
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Mar 15, 2007. Female patient, weighting 94.00 lb, was diagnosed with colon cancer, metastases to liver and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: carbohydrate antigen 19-9 increased, dehydration, diarrhoea, hyponatraemia, nausea, pancreatitis. BEVACIZUMAB dosage: 5MG/KG Q 2 WKS IV DRIP. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5270286-2
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 15, 2007. Female patient, weighting 121.3 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, disease progression. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, OXALIPLATIN. Patient died on 01/21/2007.
Bevacizumab Side Effects Report #5270564-7
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Mar 02, 2007. Female patient, 75 years of age, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, body temperature increased, dysstasia, fall, heart rate decreased, muscular weakness, spinal osteoarthritis. BEVACIZUMAB dosage: 760 MG, Q2W, INTRAVENOUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5270599-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 02, 2007. Female patient, 57 years of age, was diagnosed with breast cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: condition aggravated, neutropenia, sinusitis, sinusitis fungal. BEVACIZUMAB dosage: 718 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, CYTOXAN, PACLITAXEL, NEULASTA, CETIRIZINE, MONTELUKAST. Patient recovered.
Bevacizumab Side Effects Report #5270740-3
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Mar 19, 2007. Female patient, weighting 123.2 lb, was diagnosed with metastasis and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, encephalopathy, haemoptysis, haemorrhage. BEVACIZUMAB dosage: 10 MG/KG Q2 WEEKS IV. During the same period patient was treated with BEVACIZUMAB N. Patient was hospitalized and became disabled. Patient died on 03/03/2007.
Bevacizumab Side Effects Report #5271535-7
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 02, 2007. Male patient, 37 years of age, weighting 174.4 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DECADRON, SEROQUEL, KEPPRA, PROTONIX, VITAMIN, ALLEGRA, TRILEPTAL. Patient recovered.
Bevacizumab Side Effects Report #5272635-8
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Mar 20, 2007. Female patient, weighting 136.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, pulmonary embolism. BEVACIZUMAB dosage: 15MG/KG EVERY 3 WEEKS IV DRIP. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5275443-7
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 71 years of age, weighting 177.0 lb, was diagnosed with tonsil cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, pneumonitis. BEVACIZUMAB dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5275481-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 22, 2007. Male patient, 71 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cystitis, haemorrhage. BEVACIZUMAB dosage: 10 MG/KG DAYS 1+15 IV. During the same period patient was treated with PEMETREXED, ERLOTINIB, LIPITOR, FLOMAX, VASOTEC, ACTOS, CLARITIN, CHLORTHALID. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5275487-5
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 71 years of age, weighting 177.0 lb, was diagnosed with tonsil cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia. BEVACIZUMAB dosage: 10 MG/KG Q 2 WEEKS IV. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE, CISPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5277917-1
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 12, 2007. Male patient, 68 years of age, weighting 160.7 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: asthenia, confusional state, leukoencephalopathy. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, CAROBPLATIN. Patient died on 03/09/2007.
Bevacizumab Side Effects Report #5279562-0
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 13, 2007. Male patient, 69 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, erosive oesophagitis, nausea, weight decreased. BEVACIZUMAB dosage: 1395 MG, Q3W, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, DEXAMETHASONE, REGLAN, PACLITAXEL, EMEND, KYTRIL, PHENERGAN, PRILOSEC. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5279569-3
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 12, 2007. Male patient, 63 years of age, was diagnosed with neoplasm malignant and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, chronic obstructive pulmonary disease, condition aggravated, diverticular perforation, lung infection pseudomonal, lung neoplasm, pulmonary thrombosis, respiratory distress. BEVACIZUMAB dosage: 15 MG/MKG, Q3W, INTRAVENOUS. During the same period patient was treated with ALIMTA, LEVOTHYROXINE, VANCOMYCIN HYDROCHLORIDE, FORTAZ, FLAGYL, PROTONIX, NORVASC, PULMICORT. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5279577-2
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 12, 2007. Male patient, 68 years of age, weighting 160.7 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: brain scan abnormal, cerebral arteriosclerosis, condition aggravated, depressed level of consciousness, fall, leukoencephalopathy. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, LOVASTATIN, ATENOLOL, CARBOPLATIN, LISINOPRIL, ASPIRIN, LANTUS, HUMALOG. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5280209-8
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Mar 26, 2007. Male patient, weighting 233.0 lb, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: arterial haemorrhage, rectal haemorrhage. BEVACIZUMAB dosage: unknown. Patient was hospitalized. Patient died on 03/19/2007.
Bevacizumab Side Effects Report #5281428-7
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Mar 23, 2007. Female patient, 58 years of age, weighting 163.1 lb, was diagnosed with renal cancer metastatic, metastases to lung and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, fall, wrist fracture. BEVACIZUMAB dosage: 740 MG IV X 1. During the same period patient was treated with PROLEUKIN, ZETIA, PROTONIX, SYNTHROID, IBUPROFEN, NORVASC, BACOLFEN, TRAMADOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5282953-5
Physician from SINGAPORE reported BEVACIZUMAB problem on Mar 16, 2007. Male patient, 54 years of age, was diagnosed with colon cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, neutropenia. BEVACIZUMAB dosage: unknown. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL. Patient recovered.
Bevacizumab Side Effects Report #5283507-7
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Female patient, 68 years of age, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: glioblastoma multiforme, haematochezia, haemoglobin decreased, malignant neoplasm progression, peripheral motor neuropathy, sedation. BEVACIZUMAB dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, TOPROL, TIMOLOL MALEATE, NEXIUM, COUMADIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 03/18/2007.
Bevacizumab Side Effects Report #5284093-8
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 13, 2007. Female patient, 65 years of age, weighting 108.0 lb, was diagnosed with lung neoplasm malignant and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: chest pain, sinus tachycardia. BEVACIZUMAB dosage: 743 MG, Q3W, INTRAVENOUS. During the same period patient was treated with TAXOL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5285458-0
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 21, 2007. Male patient, 71 years of age, weighting 181.9 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: cystitis, haematuria, haemorrhage. BEVACIZUMAB dosage: 10 MG/KG, DAYS 1+15, INTRAVENOUS. During the same period patient was treated with ERLOTINIB, PEMETREXED, LIPITOR, FLOMAX, ENALAPRIL MALEATE, ACTOS, CLARITIN, ATENOLOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5287046-9
Physician from UNITED STATES reported BEVACIZUMAB problem on Mar 23, 2007. Male patient, 60 years of age, weighting 225.1 lb, was diagnosed with glioblastoma multiforme and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, deep vein thrombosis, hydrocephalus, neutrophil count decreased, pneumonia, pulmonary embolism, urinary tract infection. BEVACIZUMAB dosage: unknown. During the same period patient was treated with IRINOTECAN, LEVAQUIN, THIAMINE HYDROCHLORIDE, DEXAMETHASONE, HEPARIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5287051-2
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Mar 19, 2007. Male patient, 68 years of age, weighting 160.7 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, asthenia, bacteria urine identified, blood glucose increased, cerebrovascular disorder, confusional state, depressed level of consciousness, drooling, leukoencephalopathy. BEVACIZUMAB dosage: unknown. During the same period patient was treated with DOCETAXEL, CARBOPLATIN, LOVASTATIN, ATENOLOL, LISINOPRIL, ASPIRIN. Patient was hospitalized. Patient died on 03/09/2007.
Bevacizumab Side Effects Report #5288013-1
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 26, 2007. Male patient, 71 years of age, weighting 172.0 lb, was diagnosed with colon cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: anastomotic complication, dyspnoea, procedural site reaction, respiratory tract irritation, thrombosis, tracheal disorder. BEVACIZUMAB dosage: 5MG/KG Q2W IV. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, LEUCOVORIN CALCIUM, LIPITOR, NIASPAN, QUANAPRIL, COREG, HEMOCYTE. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5283868-9
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Mar 19, 2007. Female patient, 63 years of age, was diagnosed with colorectal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: diarrhoea, infection, sepsis. BEVACIZUMAB dosage: 450 MG, UNK. During the same period patient was treated with CAPECITABINE, IRINOTECAN. Patient was hospitalized. Patient died on 03/19/2007.
Bevacizumab Side Effects Report #5287791-5
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Apr 02, 2007. Male patient was diagnosed with anaplastic astrocytoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, tenderness. BEVACIZUMAB dosage: 10 MG/KG. During the same period patient was treated with ERLOTINIB, KEPPRA, LEXAPRO, PROTONIX, DECADRON, DILANTIN. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5288602-4
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Mar 22, 2007. Male patient, weighting 233.7 lb, was diagnosed with colorectal cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, liver function test abnormal, renal function test abnormal. BEVACIZUMAB dosage: 700 MG, 2/WEEK. During the same period patient was treated with CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient recovered.
Showing 1-50 of 874 Next >
Drug Information: Bevacizumab Injection
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a607001.html
(be va siz' yoo mab)IMPORTANT WARNING:
| Bevacizumab may cause you to develop a hole in the wall of your stomach or intestine. This is a serious and possibly life-threatening condition. If you experience any of the following symptoms, call your doctor immediately: stomach pain, constipation, nausea, vomiting, or fever.Bevacizumab may slow the healing of wounds, such as cuts made by a doctor during surgery. In some cases, bevacizumab may cause a wound that has closed to split open. This is a serious and possibly life-threatening condition. If you experience this problem, call your doctor immediately. Tell your doctor if you have recently had surgery or if you plan to have surgery. If you have recently had surgery, you should not use bevacizumab until at least 28 days have passed and until the area has completed healed. If you are scheduled to have surgery, your doctor will stop your treatment with bevacizumab at least several weeks before the surgery.Bevacizumab may cause severe, life-threatening bleeding in the lungs of people who are using bevacizumab along with chemotherapy to treat lung cancer. Tell your doctor if you have recently coughed up blood or if you cough up blood at any time during your treatment.Talk to your doctor about the risks of using bevacizumab. |
Why is this medication prescribed?
Bevacizumab is used with chemotherapy to treat cancer of the colon (large intestine) or rectum that has spread to other parts of the body. Bevacizumab is also used with chemotherapy to treat certain types of lung cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumors. This may slow the growth and spread of tumors.
How should this medicine be used?
Bevacizumab comes as a solution to administer slowly into a vein. Bevacizumab is administered by a doctor or nurse in a medical office, infusion center, or hospital. Bevacizumab is usually given once every 2 weeks to treat cancer of the colon or rectum and once every 3 weeks to treat lung cancer.
It should take 90 minutes for you to receive your first dose of bevacizumab. A doctor or nurse will watch you closely to see how your body reacts to bevacizumab. If you do not have any serious problems when you receive your first dose of bevacizumab, it will usually take 30 to 60 minutes for you to receive each of your remaining doses of the medication.
Other uses for this medicine
Bevacizumab is also sometimes used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities) and other types of cancer. Talk to your doctor about the risks of using bevacizumab to treat your condition.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before receiving bevacizumab,
- tell your doctor and pharmacist if you are allergic to bevacizumab or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention anticoagulants (blood thinners) such as warfarin (Coumadin) and irinotecan (Camptosar). Also tell your doctor if you are taking or if you have ever taken an anthracycline (a type of chemotherapy used for breast cancer and some types of leukemia) such as daunorubicin (Cerubidine), doxorubicin (Adriamycin, Rubex), epirubicin (Ellence), or idarubicin (Idamycin). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you have ever been treated with radiation therapy to the left side of your chest, and if you have or have ever had cancer that spread to your brain or spine, high blood pressure, or any condition that affects your heart or blood vessels (tubes that move blood between the heart and other parts of the body).
- tell your doctor if you are pregnant or plan to become pregnant. Bevacizumab may harm the fetus and increase the risk of a pregnancy loss. You should use birth control to prevent pregnancy during your treatment with bevacizumab and for some time after you stop using the medication. If you become pregnant while using bevacizumab, call your doctor.
- tell your doctor if you are breast-feeding. You should not breastfeed during your treatment with bevacizumab and for some time after you stop using the medication.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
If you miss an appointment to receive a dose of bevacizumab, call your doctor as soon as possible.
What side effects can this medication cause?
Bevacizumab may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- dizziness
- fainting
- nosebleeds
- bleeding gums
- weakness
- loss of appetite
- heartburn
- change in ability to taste food
- diarrhea
- weight loss
- dry mouth
- sores on the skin or in the mouth
- voice changes
Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:
- nosebleeds that cause dizziness or fainting or that do not stop after 10 to 15 minutes
- unusual bruising or bleeding
- black or bloody stools
- bright red blood in stools
- vomit that is bloody or looks like coffee grounds
- coughing, gagging, or choking after eating or drinking
- severe vaginal bleeding
- headache
- neck pain
- slow or difficult speech
- dizziness or faintness
- weakness or numbness of an arm or leg
- chest pain
- pain in the arms, neck, or upper back
- shortness of breath
- seizures
- extreme tiredness
- confusion
- change in vision or loss of vision
- sore throat, fever, chills, and other signs of infection
- swelling of the face, eyes, stomach, hands, feet, ankles, or lower legs
- unexplained weight gain
- foamy urine
- dry, hacking cough
- pain, tenderness, warmth, redness, or swelling in one leg only
- redness, itching, or scaling of the skin
Bevacizumab may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.
What storage conditions are needed for this medicine?
Bevacizumab will be stored in the medical office, infusion center, or hospital.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- headache
What other information should I know?
Keep all appointments with your doctor. Your doctor will check your blood pressure and test your urine regularly during your treatment with bevacizumab.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|